País: Reino Unido
Língua: inglês
Origem: HMA (Heads of Medicines Agencies)
phytomenadione 10 mg/ml
TVM
QB02BA01
Solution for injection
phytomenadione
Dogs
2009-10-15
12432 SPC D90 SPC 1) NAME OF THE VETERINARY MEDICINAL PRODUCT Vitamin K 1 Laboratoire TVM, Solution for injection for dogs, 10 mg/ml (for UK, IT, D, ES, AT, NL) Vitamine K 1 injectable TVM, Solution for injection for dogs, 10 mg/ml (for FR) 2) QUALITATIVE AND QUANTITATIVE COMPOSITION: 1ml contains : Active substance: Phytomenadione 10,0 mg For full list of excipients, see section 6.1. 3) PHARMACEUTICAL FORM Solution for injection Yellow, clear to slightly opalescent liquid. 4) CLINICAL PARTICULARS: 4.1 - TARGET SPECIES Dogs 4.2 - INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In dogs: Emergency treatment of anticoagulant rodenticide poisoning, before starting oral treatment. 4.3 - CONTRAINDICATIONS Do not use in cases of known hypersensitivity to the active substance or to any of the excipients. 4.4 - SPECIAL WARNINGS FOR EACH TARGET SPECIES As the anticoagulant effects of rodenticides are known to be long lasting it is recommended to start Vitamin K 1 supplementation with an oral formulation within 12 hours of the last injection for a duration of 3 weeks, and to evaluate the coagulation status (via one stage prothrombin times) 48 hours after the last administration. In the case of persistence of the anticoagulant in the body, the duration of treatment can be extended as long as the anticoagulant persists, to avoid relapse (the coagulation status has to be evaluated 48 hours after each attempt of treatment cessation). 4.5 - SPECIAL PRECAUTIONS FOR USE _I.SPECIAL PRECAUTIONS F Leia o documento completo